Weekly Investment Analysts’ Ratings Updates for Transcat (TRNS)

Several analysts have recently updated their ratings and price targets for Transcat (NASDAQ: TRNS):

  • 2/14/2018 – Transcat was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $18.00 price target on the stock. According to Zacks, “Transcat, Inc. distributes test and measurement instruments and provides accredited calibration services to a variety of industries including life sciences, pharmaceutical, petroleum refining, chemical manufacturing, public utility, pulp and paper, communications, automotive and aerospace. “
  • 2/10/2018 – Transcat was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Transcat, Inc. distributes test and measurement instruments and provides accredited calibration services to a variety of industries including life sciences, pharmaceutical, petroleum refining, chemical manufacturing, public utility, pulp and paper, communications, automotive and aerospace. “
  • 2/9/2018 – Transcat is now covered by analysts at Roth Capital. They set a “buy” rating and a $20.00 price target on the stock.
  • 2/5/2018 – Transcat had its price target raised by analysts at Singular Research from $15.30 to $20.00. They now have a “buy” rating on the stock.
  • 2/3/2018 – Transcat was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $18.00 price target on the stock. According to Zacks, “Transcat, Inc. distributes test and measurement instruments and provides accredited calibration services to a variety of industries including life sciences, pharmaceutical, petroleum refining, chemical manufacturing, public utility, pulp and paper, communications, automotive and aerospace. “
  • 1/2/2018 – Transcat was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Transcat, Inc. distributes test and measurement instruments and provides accredited calibration services to a variety of industries including life sciences, pharmaceutical, petroleum refining, chemical manufacturing, public utility, pulp and paper, communications, automotive and aerospace. “
  • 12/20/2017 – Transcat was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Transcat, Inc. distributes test and measurement instruments and provides accredited calibration services to a variety of industries including life sciences, pharmaceutical, petroleum refining, chemical manufacturing, public utility, pulp and paper, communications, automotive and aerospace. “

Transcat, Inc. (NASDAQ TRNS) traded up $0.02 during trading on Wednesday, hitting $15.75. The company had a trading volume of 700 shares, compared to its average volume of 17,575. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.38. Transcat, Inc. has a fifty-two week low of $11.02 and a fifty-two week high of $16.49. The company has a market capitalization of $112.48, a PE ratio of 23.16, a price-to-earnings-growth ratio of 2.81 and a beta of 0.40.

Transcat (NASDAQ:TRNS) last announced its quarterly earnings data on Monday, January 29th. The scientific and technical instruments company reported $0.21 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.12 by $0.09. The firm had revenue of $40.48 million during the quarter. Transcat had a return on equity of 10.03% and a net margin of 3.24%. equities analysts predict that Transcat, Inc. will post 0.7 EPS for the current fiscal year.

In other Transcat news, Director John T. Smith sold 2,000 shares of the business’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $15.70, for a total transaction of $31,400.00. Following the completion of the sale, the director now directly owns 33,100 shares of the company’s stock, valued at approximately $519,670. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 8.80% of the company’s stock.

Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).

Receive News & Ratings for Transcat Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply